Trial Profile
A phase III study to evaluate immune non inferiority and safety of the All in One liquid formulation of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV) to a licensed vaccine RotaTeq when administered as three dose series to Indian infants concomitantly with other routinely recommended vaccines for the age.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary) ; Rotavirus vaccine
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors Shantha Biotechnics
- 22 Oct 2014 New trial record